Revolutionizing Technology: STMicroelectronics and Innoscience Join Forces for GaN Development and Manufacturing

Revolutionizing Technology: STMicroelectronics and Innoscience Join Forces for GaN Development and Manufacturing Description STMicroelectronics and Innoscience have signed a GaN technology development and manufacturing agreement through a Joint Development Agreement (JDA). This partnership aims to build the future in power electronics for AI datacenters, renewable energy generation and storage, cars,

Read More »

Discover the Inspiring Story of Lipella Pharmaceuticals Co-Founder, Michael Chancellor, on the Pharmaverse Podcast!

Discover the Inspiring Story of Lipella Pharmaceuticals Co-Founder, Michael Chancellor, on the Pharmaverse Podcast! Episode titled “From Medicine to Biotech Innovation” now available PITTSBURGH, March 31, 2025 – PRISM MediaWire – Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with

Read More »

Unlocking Value: A Look into the Exciting World of Share Transactions

Unlocking Value: A Look into the Exciting World of Share Transactions Transaction in Own Shares 31 March, 2025 Shell plc (the ‘Company’) announces that on 31 March 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase: 31/03/2025

Read More »

Revolutionizing Cancer Treatment: IN8bio Unveils Groundbreaking Preclinical Findings on Innovative Gamma Delta T-cell Engager Platform at AACR Annual Meeting 2025

Revolutionizing Cancer Treatment: IN8bio Unveils Groundbreaking Preclinical Findings on Innovative Gamma Delta T-cell Engager Platform at AACR Annual Meeting 2025 New York, March 31, 2025 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies for cancer and autoimmune diseases, announced today a

Read More »

Breaking News: Tharimmune Receives Encouraging FDA Response on NDA Journey for TH104 in Preventing R-Related Illness

Breaking News: Tharimmune Receives Encouraging FDA Response on NDA Journey for TH104 in Preventing R-Related Illness Description: Tharimmune, Inc. (Nasdaq:THAR), a clinical-stage biotechnology company specializing in immunology and inflammation, has received positive feedback on its New Drug Application (NDA) submission for TH104 via the 505(b)(2) pathway. The company is leveraging

Read More »

Unlock the Latest News: Discover the Top Press Releases on The Newswire!

Unlock the Latest News: Discover the Top Press Releases on The Newswire! Vancouver, British Columbia – March 31, 2025 – TheNewswire – Rackla Metals Inc. (TSX-V: RAK) Announces Increased Non-Brokered Private Placement The Newswire is always buzzing with the latest updates and announcements from various companies. Rackla Metals Inc. (TSX-V:

Read More »